Presentation Information
[F2-60]A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection
*Kei Konishi1,2,3, Yoshiyuki Taoda4, Manabu Igarashi3, Takao Shishido2, Kazuya Yasuo4, Yasuko Orba1,3, Hirofumi Sawa1,5, Michihito Sasaki1,3, Akihiko Sato1,2,3 (1. Institute for Vaccine Research and Development, Hokkaido University (Japan), 2. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd. (Japan), 3. International Institute for Zoonosis Control, Hokkaido University (Japan), 4. Laboratory for Medicinal Chemistry Research, Shionogi & Co., Ltd. (Japan), 5. One Health Research Center, Hokkaido University (Japan))

Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
